Combined Oral Contraceptive Pills with Testosterone Therapy
Introduction to Contraception and Hormone Therapy
- Combining oral contraceptive pills with testosterone therapy is pharmacologically counterproductive and not recommended, as COCs are specifically designed to suppress androgens including testosterone, while testosterone therapy aims to increase androgen levels—these opposing mechanisms directly antagonize each other, according to the American Academy of Dermatology 1, 2
Mechanism of Action Conflict
- COCs work through multiple anti-androgenic mechanisms, including inhibition of gonadotropin secretion, which reduces ovarian and adrenal androgen production, as noted by the American Academy of Dermatology 1
- COCs increase sex hormone-binding globulin (SHBG) production, which binds and inactivates free testosterone, as reported by the American Academy of Dermatology 1
Clinical Context: Contraception for Testosterone Users
- Testosterone alone is not reliable contraception, despite suppressing ovulation in many users, and progestin-only contraceptives are the appropriate choice for transgender men on testosterone therapy who need contraception, according to the American Heart Association, as published in Hypertension 3, 2
- Progestin-only pills (POPs) do not significantly affect blood pressure and avoid the estrogen component that would oppose testosterone effects, as noted in Hypertension 3, 4
Cardiovascular and Safety Considerations
- Current COC use increases myocardial infarction risk (RR 1.6-1.7) and ischemic stroke risk (RR 1.7-1.9), as reported by the British Medical Journal 5, 6
- The risk amplifies dramatically with comorbidities: hypertension (MI risk OR 6-68), dyslipidemia (MI risk OR 25), and migraine (stroke risk OR 2.08-16.9), according to the British Medical Journal 5, 6
- Venous thromboembolism risk increases from 1 per 10,000 to 3-4 per 10,000 woman-years, as noted by the American Academy of Dermatology and the American College of Cardiology 1, 2